Shedding the load of hypertension: The proteolytic processing of angiotensin-converting enzyme

South African Medical Journal

Volumn 102, Issue 6, 2012, Pages 461-464

  Ehlers, Mario R W ^a,b   Gordon, Kerry ^b   Schwager, Sylva L U ^b   Sturrock, Edward D ^b  

^a Immune Tolerance Network   (United States)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM10 ENDOPEPTIDASE; ALPHA SECRETASE; AMYLOID PRECURSOR PROTEIN; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INTERLEUKIN 6; NEUROPEPTIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; ZINC BINDING PROTEIN; ADAM PROTEIN; MATRIX METALLOPROTEINASE; MEMBRANE PROTEIN;

ALZHEIMER DISEASE; BLOOD PRESSURE REGULATION; CELL ADHESION; CELL MIGRATION; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; ENZYME MECHANISM; GENE EXPRESSION; GENE MUTATION; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; REGULATORY MECHANISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SPERMATOZOON; TUMOR GROWTH; ENZYMOLOGY; GENETICS; METABOLISM; MOLECULARLY TARGETED THERAPY;

ADAM PROTEINS; HUMANS; HYPERTENSION; MATRIX METALLOPROTEINASES; MEMBRANE PROTEINS; MOLECULAR TARGETED THERAPY; PEPTIDYL-DIPEPTIDASE A;

EID: 84865129718     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: 10.7196/samj.5596     Document Type: Review

References (19)

1. Ehlers MR, Riordan JF. Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteins. Biochemistry 1991;30(42):10065-10074.
2. Scheller J, Chalaris A, Garbers C, Rose-John S. ADAM17: a molecular switch to control inflammation and tissue regeneration. Trends Immunol 2011;32(8):380-387.
3. Ehlers MR, Chen YN, Riordan JF. Spontaneous solubilization of membrane-bound human testis angiotensin-converting enzyme expressed in Chinese hamster ovary cells. Proc Natl Acad Sci USA 1991;88(3):1009-1013.
4. Acharya KR, Sturrock ED, Riordan JF, Ehlers MR. ACE revisited: a new target for structure-based drug design. Nat Rev Drug Discov 2003;2(11):891-902.
5. Ehlers MR, Riordan JF. Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry 1989;28(13):5311-5318.
6. Shen XZ, Xiao HD, Li P, et al. New insights into the role of angiotensin-converting enzyme obtained from the analysis of genetically modified mice. J Mol Med (Berl) 2008;86(6):679-684.
7. Ehlers MR, Schwager SL, Scholle RR, Manji GA, Brandt WF, Riordan JF. Proteolytic release of membrane-bound angiotensin-converting enzyme: role of the juxtamembrane stalk sequence. Biochemistry 1996;35(29):9549-9559.
8. Beldent V, Michaud A, Bonnefoy C, Chauvet MT, Corvol P. Cell surface localization of proteolysis of human endothelial angiotensin I-converting enzyme. Effect of the amino-terminal domain in the solubilization process. J Biol Chem 1995;270(48):28962-28969.
9. Woodman ZL, Schwager SL, Redelinghuys P, Carmona AK, Ehlers MR, Sturrock ED. The N domain of somatic angiotensin-converting enzyme negatively regulates ectodomain shedding and catalytic activity. Biochem J 2005;389(Pt 3):739-744.
10. Allinson TM, Parkin ET, Condon TP, et al. The role of ADAM10 and ADAM17 in the ectodomain shedding of angiotensin converting enzyme and the amyloid precursor protein. Eur J Biochem 2004;271(12):2539-2547.
11. Eyries M, Michaud A, Deinum J, et al. Increased shedding of angiotensin-converting enzyme by a mutation identified in the stalk region. J Biol Chem 2001;276(8):5525-5532.
12. Nesterovitch AB, Hogarth KD, Adarichev VA, et al. Angiotensin I-converting enzyme mutation (Trp1197Stop) causes a dramatic increase in blood ACE. PLoS One 2009;4(12):e8282.
13. Danilov SM, Gordon K, Nesterovitch AB, et al. An angiotensin I-converting enzyme mutation (Y465D) causes a dramatic increase in blood ACE via accelerated ACE shedding. PLoS One 2011;6(10):e25952.
14. Harrison S, Geppetti P. Substance p. Int J Biochem Cell Biol 2001;33(6):555-576.
15. Ehlers MRW, Riordan JF. Angiotensin-converting enzyme: zinc and inhibitor-binding stoichiometries of the somatic and testis isozymes. Biochemistry 1991;30:7118-7126.
16. Nagi DK, Foy CA, Mohamed-Ali V, Yudkin JS, Grant PJ, Knowler WC. Angiotensin-1-converting enzyme (ACE) gene polymorphism, plasma ACE levels, and their association with the metabolic syndrome and electrocardiographic coronary artery disease in Pima Indians. Metabolism 1998;47(5):622-626.
17. Dzau VJ, Bernstein K, Celermajer D, et al. Pathophysiologic and therapeutic importance of tissue ACE: a consensus report. Cardiovasc Drugs Ther 2002;16(2):149-160.
18. Douglas RG, Ehlers MRW, Sturrock ED. Vasopeptidase inhibition-solving the cardiovascular puzzle? Drugs of the Future 2011;36(1):33-43.
19. Saftig P, Reiss K. The 'A disintegrin and metalloproteases' ADAM10 and ADAM17: novel drug targets with therapeutic potential? Eur J Cell Biol 2011;90(6-7):527-535.